Literature DB >> 16027221

SNAREs can promote complete fusion and hemifusion as alternative outcomes.

Claudio G Giraudo1, Chuan Hu, Daoqi You, Avram M Slovic, Eugene V Mosharov, David Sulzer, Thomas J Melia, James E Rothman.   

Abstract

Using a cell fusion assay, we show here that in addition to complete fusion SNAREs also promote hemifusion as an alternative outcome. Approximately 65% of events resulted in full fusion, and the remaining 35% in hemifusion; of those, approximately two thirds were permanent and approximately one third were reversible. We predict that this relatively close balance among outcomes could be tipped by binding of regulatory proteins to the SNAREs, allowing for dynamic physiological regulation between full fusion and reversible kiss-and-run-like events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027221      PMCID: PMC2171417          DOI: 10.1083/jcb.200501093

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  53 in total

1.  Hemifusion between cells expressing hemagglutinin of influenza virus and planar membranes can precede the formation of fusion pores that subsequently fully enlarge.

Authors:  V I Razinkov; G B Melikyan; F S Cohen
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

Review 2.  Regulation of transmitter release by Unc-13 and its homologues.

Authors:  N Brose; C Rosenmund; J Rettig
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

3.  A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion.

Authors:  G B Melikyan; R M Markosyan; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

4.  Compartmental specificity of cellular membrane fusion encoded in SNARE proteins.

Authors:  J A McNew; F Parlati; R Fukuda; R J Johnston; K Paz; F Paumet; T H Söllner; J E Rothman
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

5.  Hemifusion in SNARE-mediated membrane fusion.

Authors:  Yibin Xu; Fan Zhang; Zengliu Su; James A McNew; Yeon-Kyun Shin
Journal:  Nat Struct Mol Biol       Date:  2005-04-10       Impact factor: 15.369

6.  Distinct SNARE complexes mediating membrane fusion in Golgi transport based on combinatorial specificity.

Authors:  Francesco Parlati; Oleg Varlamov; Keren Paz; James A McNew; David Hurtado; Thomas H Söllner; James E Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  Geranylgeranylated SNAREs are dominant inhibitors of membrane fusion.

Authors:  E Grote; M Baba; Y Ohsumi; P J Novick
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

8.  Close is not enough: SNARE-dependent membrane fusion requires an active mechanism that transduces force to membrane anchors.

Authors:  J A McNew; T Weber; F Parlati; R J Johnston; T J Melia; T H Söllner; J E Rothman
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

9.  A t-SNARE of the endocytic pathway must be activated for fusion.

Authors:  F Paumet; B Brügger; F Parlati; J A McNew; T H Söllner; J E Rothman
Journal:  J Cell Biol       Date:  2001-12-10       Impact factor: 10.539

10.  The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.

Authors:  R T Armstrong; A S Kushnir; J M White
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  60 in total

1.  Direct visualization of large and protein-free hemifusion diaphragms.

Authors:  Jörg Nikolaus; Martin Stöckl; Dieter Langosch; Rudolf Volkmer; Andreas Herrmann
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

2.  Residue-specific side-chain packing determines the backbone dynamics of transmembrane model helices.

Authors:  Stefan Quint; Simon Widmaier; David Minde; Daniel Hornburg; Dieter Langosch; Christina Scharnagl
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

3.  Conical electron tomography of a chemical synapse: vesicles docked to the active zone are hemi-fused.

Authors:  G A Zampighi; L M Zampighi; N Fain; S Lanzavecchia; S A Simon; E M Wright
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

4.  Seeing is believing: the stalk intermediate.

Authors:  Barry R Lentz
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

5.  Ensemble molecular dynamics yields submillisecond kinetics and intermediates of membrane fusion.

Authors:  Peter M Kasson; Nicholas W Kelley; Nina Singhal; Marija Vrljic; Axel T Brunger; Vijay S Pande
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

6.  Multiple intermediates in SNARE-induced membrane fusion.

Authors:  Tae-Young Yoon; Burak Okumus; Fan Zhang; Yeon-Kyun Shin; Taekjip Ha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-13       Impact factor: 11.205

7.  Evidence of cholesterol accumulated in high curvature regions: implication to the curvature elastic energy for lipid mixtures.

Authors:  Wangchen Wang; Lin Yang; Huey W Huang
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

8.  Transmembrane proteins are not required for early stages of nuclear envelope assembly.

Authors:  Corinne Ramos; Elvira R Rafikova; Kamran Melikov; Leonid V Chernomordik
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

9.  SM protein Munc18-2 facilitates transition of Syntaxin 11-mediated lipid mixing to complete fusion for T-lymphocyte cytotoxicity.

Authors:  Waldo A Spessott; Maria L Sanmillan; Margaret E McCormick; Vineet V Kulkarni; Claudio G Giraudo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

10.  Sequence-specific conformational flexibility of SNARE transmembrane helices probed by hydrogen/deuterium exchange.

Authors:  Walter Stelzer; Bernhard C Poschner; Holger Stalz; Albert J Heck; Dieter Langosch
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.